662 reports of this reaction
2.1% of all NICOTINE POLARILEX reports
#8 most reported adverse reaction
TREATMENT NONCOMPLIANCE is the #8 most commonly reported adverse reaction for NICOTINE POLARILEX, manufactured by AmerisourceBergen (Good Neighbor Pharmacy) 46122. There are 662 FDA adverse event reports linking NICOTINE POLARILEX to TREATMENT NONCOMPLIANCE. This represents approximately 2.1% of all 31,749 adverse event reports for this drug.
Patients taking NICOTINE POLARILEX who experience treatment noncompliance should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TREATMENT NONCOMPLIANCE is a less commonly reported adverse event for NICOTINE POLARILEX, but still significant enough to appear in the safety profile.
In addition to treatment noncompliance, the following adverse reactions have been reported for NICOTINE POLARILEX:
The following drugs have also been linked to treatment noncompliance in FDA adverse event reports:
TREATMENT NONCOMPLIANCE has been reported as an adverse event in 662 FDA reports for NICOTINE POLARILEX. This does not prove causation, but indicates an association observed in post-market surveillance data.
TREATMENT NONCOMPLIANCE accounts for approximately 2.1% of all adverse event reports for NICOTINE POLARILEX, making it a notable side effect.
If you experience treatment noncompliance while taking NICOTINE POLARILEX, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.